Australia markets closed

INOVIQ Ltd (EGQ0.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.2840+0.0080 (+2.90%)
At close: 08:05AM CEST
Full screen
Previous close0.2760
Open0.2840
Bid0.2880 x N/A
Ask0.3200 x N/A
Day's range0.2840 - 0.2840
52-week range0.2620 - 0.5550
Volume85
Avg. volume0
Market cap27.894M
Beta (5Y monthly)2.17
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • PR Newswire

    EXCELLENT CLINICAL DATA FOR SUBB2M/CA15-3 BREAST CANCER TEST

    INOVIQ Limited (ASX:IIQ) (INOVIQ or the Company), a developer of next-generation exosome solutions and precision diagnostics, is pleased to announce excellent results from an independent clinical validation study of its SubB2M/CA15-3 test for breast cancer detection. The study showed high accuracy (87%), sensitivity (81%), and specificity (93%) for INOVIQ's SubB2M test, outperforming a leading approved CA15-3 test.